Xue-Lei Ma (Xuelei Ma)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 55

Top Venues

Contrast media & molecular imaging

MedComm

BMC cancer

Clinical Medicine Insights. Oncology

West China Hospital, Sichuan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

West China Hospital, Sichuan University

China

Associate Professor :: Biotherapy Department

Publications

Xinggang Yang, Jiaqing Yang, Jia Li, Junyan Leng, Yu Qiu, Xue-Lei Ma
Diagnostic Performance of Node Reporting and Data System Magnetic Resonance Imaging Score in Detecting Metastatic Cervical Lymph Nodes of Nasopharyngeal Carcinoma. Clinical Medicine Insights. Oncology 18 (2024)
Yufu Peng, Jing Yu, Fei Liu, Leyi Tang, Bo Li, Wei Zhang, Kefei Chen, Haili Zhang, Yonggang Wei, Xue-Lei Ma, Hubing Shi
Accumulation of TOX high mobility group box family member 3 promotes the oncogenesis and development of hepatocellular carcinoma through the MAPK signaling pathway. MedComm 5 (3) (2024)
Yufu Peng, Jing Yu, Fei Liu, Leyi Tang, Bo Li, Wei Zhang, Kefei Chen, Haili Zhang, Yonggang Wei, Xue-Lei Ma, Hubing Shi
Accumulation of TOX high mobility group box family member 3 promotes the oncogenesis and development of hepatocellular carcinoma through the MAPK signaling pathway. MedComm 5 (3) (2024)
Jiaqing Yang, Jing Huang, Deqian Han, Xue-Lei Ma
Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review. Clinical Medicine Insights. Oncology 18 (2024)
Jiaqing Yang, Jing Huang, Deqian Han, Xue-Lei Ma
Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review. Clinical Medicine Insights. Oncology 18 (2024)
Zedong Jiang, Qianlong Kang, Hong Qian, Zhijie Xu, Huan Tong, Jiaqing Yang, Li Li, Renwei Li, Guangqi Li, Fei Chen, Nan Lin, Yunuo Zhao, Hua-Shan Shi, Juan Huang, Xue-Lei Ma
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Nan Lin, Xueyan Zhou, Weichang Chen, Chengyuan He, Xiaoxuan Wang, Yuhao Wei, Zhiwen Long, Tao Shen, Lingyu Zhong, Chan Yang, Tingting Dai, Hao Zhang, Hubing Shi, Xue-Lei Ma
Development and validation of a point-of-care nursing mobile tool to guide the diagnosis of malnutrition in hospitalized adult patients: a multicenter, prospective cohort study. MedComm 5 (4) (2024)
Zedong Jiang, Qianlong Kang, Hong Qian, Zhijie Xu, Huan Tong, Jiaqing Yang, Li Li, Renwei Li, Guangqi Li, Fei Chen, Nan Lin, Yunuo Zhao, Hua-Shan Shi, Juan Huang, Xue-Lei Ma
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Yun Chen, Pei-Pei Wang, Yang Hu, Yong Yuan, Yu-Shang Yang, Hua-Shan Shi, Qing Hao, Zhen Lin, Jiang-Fang Tian, Yue Zheng, Ting Liu, Pan-Pan Lin, Heng Xu, Xue-Lei Ma, Li Yang, Zhen-Yu Ding
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial. British journal of cancer (2024)
Nan Lin, Xueyan Zhou, Weichang Chen, Chengyuan He, Xiaoxuan Wang, Yuhao Wei, Zhiwen Long, Tao Shen, Lingyu Zhong, Chan Yang, Tingting Dai, Hao Zhang, Hubing Shi, Xue-Lei Ma
Development and validation of a point-of-care nursing mobile tool to guide the diagnosis of malnutrition in hospitalized adult patients: a multicenter, prospective cohort study. MedComm 5 (4) (2024)
Zedong Jiang, Qianlong Kang, Hong Qian, Zhijie Xu, Huan Tong, Jiaqing Yang, Li Li, Renwei Li, Guangqi Li, Fei Chen, Nan Lin, Yunuo Zhao, Hua-Shan Shi, Juan Huang, Xue-Lei Ma
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. Signal transduction and targeted therapy 9 (1) (2024)
Nan Lin, Xueyan Zhou, Weichang Chen, Chengyuan He, Xiaoxuan Wang, Yuhao Wei, Zhiwen Long, Tao Shen, Lingyu Zhong, Chan Yang, Tingting Dai, Hao Zhang, Hubing Shi, Xue-Lei Ma
Development and validation of a point-of-care nursing mobile tool to guide the diagnosis of malnutrition in hospitalized adult patients: a multicenter, prospective cohort study. MedComm 5 (4) (2024)
Xinggang Yang, Jiaqing Yang, Jia Li, Junyan Leng, Yu Qiu, Xue-Lei Ma
Diagnostic Performance of Node Reporting and Data System Magnetic Resonance Imaging Score in Detecting Metastatic Cervical Lymph Nodes of Nasopharyngeal Carcinoma. Clinical Medicine Insights. Oncology 18 (2024)
Xudong Chen, Xuyuan Shi, Zhiruo Yu, Xue-Lei Ma
High-intensity interval training in breast cancer patients: A systematic review and meta-analysis. Cancer medicine (2023)
Jiyun Pang, Weigang Xiu, Xue-Lei Ma
Application of Artificial Intelligence in the Diagnosis, Treatment, and Prognostic Evaluation of Mediastinal Malignant Tumors. Journal of clinical medicine 12 (8) (2023)
Jiyun Pang, Weigang Xiu, Xue-Lei Ma
Application of Artificial Intelligence in the Diagnosis, Treatment, and Prognostic Evaluation of Mediastinal Malignant Tumors. Journal of clinical medicine 12 (8) (2023)
Jiyun Pang, Weigang Xiu, Xue-Lei Ma
Application of Artificial Intelligence in the Diagnosis, Treatment, and Prognostic Evaluation of Mediastinal Malignant Tumors. Journal of clinical medicine 12 (8) (2023)
Jiyun Pang, Weigang Xiu, Xue-Lei Ma
Application of Artificial Intelligence in the Diagnosis, Treatment, and Prognostic Evaluation of Mediastinal Malignant Tumors. Journal of clinical medicine 12 (8) (2023)
Shiqi Nong, Xiaoyue Han, Yu Xiang, Yuran Qian, Yuhao Wei, Tingyue Zhang, Keyue Tian, Kai Shen, Jing Yang, Xue-Lei Ma
Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm 4 (2) (2023)
Shiqi Nong, Xiaoyue Han, Yu Xiang, Yuran Qian, Yuhao Wei, Tingyue Zhang, Keyue Tian, Kai Shen, Jing Yang, Xue-Lei Ma
Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm 4 (2) (2023)
Qingfang Li, Linyan Chen, Hongyu Jin, Yunuo Zhao, Zeng Hao, Xue-Lei Ma
Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis. Clinical Medicine Insights. Oncology 16 (2022)
Ruolan Xia, Maosen Xu, Jing Yang, Xue-Lei Ma
The role of Hedgehog and Notch signaling pathway in cancer. Molecular biomedicine 3 (1) (2022)
Ruolan Xia, Maosen Xu, Jing Yang, Xue-Lei Ma
The role of Hedgehog and Notch signaling pathway in cancer. Molecular biomedicine 3 (1) (2022)
Hanyue Xu, Xiuhe Zou, Yunuo Zhao, Tao Zhang, Youyin Tang, Aiping Zheng, Xianghong Zhou, Xue-Lei Ma
Differentiation of Intrahepatic Cholangiocarcinoma and Hepatic Lymphoma Based on Radiomics and Machine Learning in Contrast-Enhanced Computer Tomography. Technology in cancer research & treatment 20 (2022)
Gui-Hong Liu, Tao Chen, Xin Zhang, Xue-Lei Ma, Hua-Shan Shi
Small molecule inhibitors targeting the cancers. MedComm 3 (4) (2022)
Yuhan Yang, Yin Zhou, Chen Zhou, Xuemei Zhang, Xue-Lei Ma
MRI-Based Computer-Aided Diagnostic Model to Predict Tumor Grading and Clinical Outcomes in Patients With Soft Tissue Sarcoma. Journal of magnetic resonance imaging : JMRI 56 (6) (2022)
Ting Liu, Shuang Dai, Hao Zhang, Xi Zhong, Zhenyu Ding, Xue-Lei Ma
The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: Bayesian network meta-analysis. Head & neck (2021)
Weijia Huang, Jingwen Luo, Xianghong Zhou, Yunuo Zhao, Tao Zhang, Xue-Lei Ma
Nomograms for Predicting Prognosis of Primary Mediastinal Seminoma: A Population-Based Study. Journal of oncology 2021 (2021)
Chaoyue Chen, Xuejin Ou, Hui Li, Yanjie Zhao, Fengnian Zhao, Shengliang Zhou, Xue-Lei Ma
Contrast-Enhanced CT Texture Analysis: a New Set of Predictive Factors for Small Cell Lung Cancer. Molecular imaging and biology 22 (3) (2021)
Dan Pu, Qian Xu, Lai-Yan Zhou, Yu-Wen Zhou, Ji-Yan Liu, Xue-Lei Ma
Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors. Thoracic cancer 12 (21) (2021)
Linyan Chen, Hao Zeng, Mingxuan Zhang, Yuling Luo, Xue-Lei Ma
Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma. Cancer medicine 10 (13) (2021)
Ting Zhang, Jing Sun, Jinying Li, Yunuo Zhao, Tao Zhang, Ruoning Yang, Xue-Lei Ma
Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies. BMC cancer 21 (1) (2021)
Chune Yu, Dan Luo, Jing Yu, Min Zhang, Xiaobo Zheng, Guangchao Xu, Jiaxin Wang, Huiling Wang, Yufei Xu, Ke Jiang, Jie Xu, Xue-Lei Ma, Jing Jing, Hubing Shi
Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer. Oncogene (2021)
Jing Peng, Tao Zhang, Hang Wang, Xue-Lei Ma
The Value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the Diagnosis of Hepatocellular Carcinoma:: A Meta-Analysis. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2021)
Yunuo Zhao, Jing Yang, Meng Luo, Yanfei Yang, Xinli Guo, Tao Zhang, Jianqi Hao, Yunqian Yao, Xue-Lei Ma
Contrast-Enhanced CT-based Textural Parameters as Potential Prognostic Factors of Survival for Colorectal Cancer Patients Receiving Targeted Therapy. Molecular imaging and biology 23 (3) (2020)
Linghong Guo, Honghong Ren, Lutong Pu, Xingyu Zhu, Yin Liu, Xue-Lei Ma
The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study. Cancer management and research 12 (2020)
Xianghong Zhou, Qingyang Ning, Kun Jin, Tao Zhang, Xue-Lei Ma
Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy. BMC cancer 20 (1) (2020)
Hao Zeng, Xindi Song, Jianrui Ji, Linyan Chen, Qimeng Liao, Xue-Lei Ma
HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC. BMC cancer 20 (1) (2020)
Manni Wang, Hui Xu, Liu Xiao, Wenpeng Song, Sha Zhu, Xue-Lei Ma
Prognostic Value of Functional Parameters of 18F-FDG-PET Images in Patients with Primary Renal/Adrenal Lymphoma. Contrast media & molecular imaging 2019 (2019)
Linghong Guo, Yuanyuan Hu, Xi Chen, Qingfang Li, Benling Wei, Xue-Lei Ma
Safety and efficacy profile of cyclin-dependent kinases 4/6 inhibitor palbociclib in cancer therapy: A meta-analysis of clinical trials. Cancer medicine 8 (4) (2019)
Xue-Lei Ma, Wenwu Ling, Fan Xia, Yifan Zhang, Chenjing Zhu, Jialing He
Application of Contrast-Enhanced Ultrasound (CEUS) in Lymphomatous Lymph Nodes: A Comparison between PET/CT and Contrast-Enhanced CT. Contrast media & molecular imaging 2019 (2019)
Yi Zhou, Xue-Lei Ma, Lu-Tong Pu, Ruo-Fan Zhou, Xue-Jin Ou, Rong Tian
Prediction of Overall Survival and Progression-Free Survival by the 18F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma. Contrast media & molecular imaging 2019 (2019)
Hao Zeng, Hui Li, Yunuo Zhao, Linyan Chen, Xue-Lei Ma
Transcripto-based network analysis reveals a model of gene activation in tongue squamous cell carcinomas. Head & neck 41 (12) (2019)
Chaoyue Chen, Hongyu Zhuo, Yanping Qian, Xue-Lei Ma
Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy. Contrast media & molecular imaging 2019 (2019)
Fei Mo, Xue-Lei Ma, Xiaobei Liu, Ruofan Zhou, Yunuo Zhao, Hui Zhou
Altered CSF Proteomic Profiling of Paediatric Acute Lymphocytic Leukemia Patients with CNS Infiltration. Journal of oncology 2019 (2019)
Jiarui Xiao, Yizi Jin, Ji Nie, Fukun Chen, Xue-Lei Ma
Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis. BMC cancer 19 (1) (2019)
Yuan Cheng, Yinan Xiao, Ruofan Zhou, Yi Liao, Jing Zhou, Xue-Lei Ma
Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma. BMC cancer 19 (1) (2019)
Xuejin Ou, Jian Wang, Ruofan Zhou, Sha Zhu, Fuwen Pang, Yi Zhou, Rong Tian, Xue-Lei Ma
Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma. Contrast media & molecular imaging 2019 (2019)
Xuejin Ou, Jing Zhang, Jian Wang, Fuwen Pang, Yongsheng Wang, Xiawei Wei, Xue-Lei Ma
Radiomics based on 18 F-FDG PET/CT could differentiate breast carcinoma from breast lymphoma using machine-learning approach: A preliminary study. Cancer medicine 9 (2) (2019)
Zhihang Tao, Stanley Xiangyu Li, Kai Shen, Yunuo Zhao, Hao Zeng, Xue-Lei Ma
Safety and Efficacy Profile of Neratinib: A Systematic Review and Meta-Analysis of 23 Prospective Clinical Trials. Clinical drug investigation 39 (1) (2019)
Jing Yang, Xinli Guo, Hao Zhang, Weiwei Zhang, Jinen Song, Hui Xu, Xue-Lei Ma
Differential diagnosis of pancreatic serous cystadenoma and mucinous cystadenoma: utility of textural features in combination with morphological characteristics. BMC cancer 19 (1) (2019)
Jing Yang, Sha Zhu, Fuwen Pang, Miao Xu, Yiting Dong, Jianqi Hao, Xue-Lei Ma
Functional Parameters of 18F-FDG PET/CT in Patients with Primary Testicular Diffuse Large B-Cell Lymphoma. Contrast media & molecular imaging 2018 (2018)
Linyan Chen, Yiyun Fu, Haiyang Wang, Fuyao Yang, Jun Liu, Fan Xia, Xue-Lei Ma
Myoepithelial carcinoma of the nasopharynx: Rare case report with clinicopathologic and immunohistochemical features review of literature. Head & neck 40 (6) (2018)
Wenwu Ling, Xue-Lei Ma, Yan Luo, Linyan Chen, Huiyao Wang, Xiaoling Wang, Ni Chen, Hao Zeng, Yongzhong Li, Diming Cai
Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion. Contrast media & molecular imaging 2017 (2017)
Xue-Lei Ma, Xiawei Wei, Shasha Li
The Application of Functional Imaging in the Diagnosis of Tumors. Contrast media & molecular imaging 2017 (2017)

Xue-Lei Ma.css-eqlu8i{font-size:small;padding-left:4px;} (Xuelei Ma)

Publication Activity (10 Years)

Top Topics

Top Venues

Xue-Lei Ma (Xuelei Ma)